Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CRISP3 expression drives prostate cancer invasion and progression.

Endocrine-related cancer - 1 Jul 2020

Volpert Marianna, Furic Luc, Hu Jinghua, O'Connor Anne E, Rebello Richard J, Keerthikumar Shivakumar, Evans Jemma, Merriner D Jo, Pedersen John, Risbridger Gail P, McIntyre Peter, O'Bryan Moira K

Abstract excerpt

Identifying the factors stimulating prostate cancer cells migration and invasion has the potential to bring new therapeutic targets to the clinic. Cysteine-rich secretory protein 3 (CRISP3) is one of the most highly upregulated proteins during the transition of a healthy human prostatic epithelium to prostate cancer. Here we show using a genetically engineered mouse model of prostate cancer that CRISP3 production...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease Models, Animal
Share to Disease Progression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mice, Knockout

Share to Neoplasm Invasiveness

Share to Prostatic Neoplasms

Share to Salivary Proteins and Peptides

Share to Seminal Plasma Proteins

Source

Identifiers

PMID: 32357309
DOI: 10.1530/ERC-20-0092

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CRISP3 expression drives prostate cancer invasion and progression.PMID 32357309Read ↗

Cysteine- rich secretory protein 3 (CRISP3), ERG and PTEN define a molecular subtype of prostate cancer with implication to patients’ prognosisSemantic proximity Read ↗

Cysteine-Rich Secretory Protein-3 (CRISP3) Is Strongly Up-Regulated in Prostate Carcinomas with the TMPRSS2-ERG Fusion GeneSemantic proximity Read ↗

Prognostic value of ERG, PTEN, CRISP3 and SPINK1 in predicting biochemical recurrence in prostate cancerSemantic proximity Read ↗

Investigating the role of the secreted tumour suppressor Dickkopf-3 in stromal-epithelial interactions in prostate cancerSemantic proximity Read ↗

Effect of androgen deprivation therapy on the expression of prostate cancer biomarkers MSMB and MSMB-binding protein CRISP3.Semantic proximity Read ↗

Low expression of CRISP3 predicts a favorable prognosis in patients with mammary carcinomaSemantic proximity Read ↗

Exploring STEAP1 Expression in Prostate Cancer Cells in Response to Androgen Deprivation and in Small Extracellular VesiclesSemantic proximity Read ↗

The SMYD3-MAP3K2 signaling axis promotes tumor aggressiveness and metastasis in prostate cancerSemantic proximity Read ↗

CRIPTO’s multifaceted role in driving aggressive prostate cancer unveiled by in vivo, organoid, and patient dataSemantic proximity Read ↗

Analysis of Secreted Proteins for the Study of Bladder Cancer Cell AggressivenessSemantic proximity Read ↗

A Quantitative Proteomic Analysis Uncovers the Relevance of CUL3 in Bladder Cancer AggressivenessSemantic proximity Read ↗

CRISPR screening reveals SYCP3 as a key driver of metastasis in prostate cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.